Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

Figure 2

Immunostaining of prostate cancer tissue with antibodies against AMACR and PSA. Surgically resected prostate cancer tissue was immunostained with an anti-AMACR antibody (panel A) or anti-PSA antibody (panel C). The lower column (panel B) is a magnified view of the box of panel A. A clear distinction is noted between cancerous tissue with strongly positive AMACR staining (long arrow) and noncancerous glands without AMACR staining (short arrow) whereas both of them are positive for PSA.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us